DUBLIN--(BUSINESS WIRE)--The "Global Epigenetics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.
The global epigenetics market was valued at US$ 4.63 Bn in 2017, and is expected to reach US$ 16.50 Bn by 2026, expanding at a CAGR of 15.03 % from 2018 to 2026.
Epigenetics is a relatively new science in the broader field of genetics, and involves the study of the chemical modification of specific genes or gene-associated proteins. These epigenetic changes do not involve changes in the actual DNA sequence. For the purpose of the study, epigenetics market is segmented into product types such as kits (ChiP-Seq Kits, whole-genome amplification kits, 5-HMC and 5-MC analysis kits and other epigenetics kits), reagents, enzymes (DNA-modifying enzymes, protein-modifying enzymes and RNA-modifying enzymes), instruments and bioinformatics tools.
Currently, the demand for kits is highest in the market and anticipated to exhibits fastest market growth over the forecast period. Continuous advancement in the nature and precision of testing kits, rising prevalence of different diseases, wide availability of robust, simple-to-use, and cost-efficient kits, and increasing application of epigenetic technologies in research laboratories are the factors that catalyze the overall market growth.
North America is the current leader in global epigenetics market and expected to show dominance over the forecast period. Higher acceptance of newer technologies, enormous investment in R&D, and developed healthcare infrastructure are the key factors contributing to the dominance of this region. On the other hand, Asia Pacific is projected to show fastest market growth over the forecast period primarily due to increasing healthcare spending and developing healthcare infrastructure. Significant CRO activities in hubs such as India also feature the rapid pace of Asia Pacific market.
Key Topics Covered:
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Epigenetics: Market Dynamics and Outlook
Chapter 4. Global Epigenetics Market, by Product, 2016 - 2026 (US$ Mn)
Chapter 5. Global Epigenetics Market, by Technology, 2016 - 2026 (US$ Mn)
Chapter 6. Global Epigenetics Market, by Application, 2016 - 2026 (US$ Mn)
Chapter 7. Global Epigenetics Market, by Geography, 2016 - 2026 (US$ Mn)
Chapter 8. Company Profiles
- Abcam, Plc.
- Active Motif, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Diagenode, Inc.
- Illumina, Inc.
- Merck & Co., Inc.
- New England Biolabs, Inc.
- Perkinelmer, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
- Zymo Research Corp.
For more information about this report visit https://www.researchandmarkets.com/research/rx2hb8/global?w=4